The consensus price target hints at a 106.6% upside potential for MOONLAKE IMMUNO (MLTX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The mean of analysts' price targets for NovoCure (NVCR) points to a 105.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

For fiscal 2026, Honda forecasts an operating profit of 500 billion yen, indicating a contraction of 58.8% year over year.

For fiscal 2026, TM projects operating income of 3.8 trillion yen, indicating a contraction of 20.8% year over year.

Novo Nordisk announces a $2.2 billion deal with Septerna to tap the growing obesity treatment market.

Ralph Lauren (RL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LM Funding America, Inc. (NASDAQ:LMFA ) Q1 2025 Earnings Conference Call May 15, 2025 8:00 AM ET Company Participants Bruce Rodgers - Chairman, Chief Executive Officer, President Ryan Duran - President, U.S. Digital & Mining, VP, Operations Richard Russell - Chief Financial Officer Cody Fletcher - Investor Relations Conference Call Participants Michael Donovan - H.C. Wainright Operator Good day, and thank you for standing by.

BJ's (BJ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

In a market where healthcare stocks are facing their worst month in 24 years, Palantir Technologies Inc PLTR is stealing the spotlight, soaring over 32% in the past month and a staggering 500% over the past year.

Health insurance companies have been in the limelight lately after UnitedHealthcare suspended its guidance for the full year citing higher medical costs. This comes during a challenging time when the CEO Andrew Witty also stepped down for ‘personal reasons.

Honda Motor Co., Ltd.'s FY2025 earnings revealed resilient motorcycle and hybrid sales, but auto segment weakness and a 12% profit drop spooked investors. FY2026 guidance is ultra-conservative, reflecting worst-case U.S. tariff impacts and a significant step down in operating and net profit expectations. Management is mitigating tariff risks by reallocating production to U.S. plants, accelerating exports, and delaying major EV investments to preserve flexibility.

Cellectis SA's pipeline consists of allogeneic CAR T-cell therapies that have the potential to make meaningful dents in heme malignancies. The financial picture remains strong, bolstered further by a partnership with AstraZeneca. Promised data readouts in late 2025 represent important potential catalysts.

Harvard, Massachusetts--(Newsfile Corp. - May 15, 2025) - AquaBounty Technologies, Inc. (NASDAQ: AQB) ("AquaBounty" or the "Company"), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the Company's financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Net income for the quarter ended March 31, 2025 was $401 thousand compared to a net loss of $11.3 million for the quarter ended March 31, 2024.

Golub Capital BDC delivered a solid quarter with a 2% total NAV return, trading at an 11% dividend yield and a 6% discount to NAV. The company's portfolio is well-diversified with 368 positions, primarily in floating-rate first-lien loans, focusing on the software and healthcare sectors. Despite a slight NAV decline and net realized losses, GBDC's low-cost fee structure and resilient portfolio have driven strong performance, beating the median BDC by 2.5%.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.